Blood Test Study Meets Goal, Validates Epic’s Prostate Cancer Target
Xconomy
MARCH 13, 2019
In study results published Wednesday, the presence of the specific protein fragment that Epic (not to be confused with Verona, WI-based EHR software maker Epic Systems) tests for in circulating tumor cells predicted a shorter median length of survival for men whose disease has spread.
Let's personalize your content